Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
12.79
+0.33 (2.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
DAWN Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -84.29 | -188.92 | -142.18 | -70.65 | -40.51 | -12.63 |
Depreciation & Amortization | 1.37 | 0.38 | 0.53 | 0.2 | 0.16 | - |
Asset Writedown & Restructuring Costs | 55 | 3 | - | 8 | - | - |
Loss (Gain) From Sale of Investments | -5.14 | -10.08 | -2.03 | - | - | - |
Stock-Based Compensation | 48.04 | 39.34 | 27.24 | 13.32 | 0.53 | 0.11 |
Other Operating Activities | -108 | - | - | -2.11 | 26.69 | 7.56 |
Change in Accounts Payable | -0.37 | 2.32 | -1.48 | 1.54 | 0.13 | 0.01 |
Change in Other Net Operating Assets | 10.78 | 7.1 | 8.05 | 1.15 | -0.49 | 0.43 |
Operating Cash Flow | -89.48 | -146.85 | -109.87 | -48.54 | -13.49 | -4.52 |
Capital Expenditures | -0.76 | -0.22 | -0.03 | - | -0.09 | - |
Sale (Purchase) of Intangibles | -72.1 | -3 | - | -8 | - | - |
Investment in Securities | 33.88 | 131.6 | -255.05 | - | - | - |
Investing Cash Flow | 69.03 | 128.38 | -255.07 | -8 | -0.09 | - |
Long-Term Debt Issued | - | - | - | - | - | 1 |
Net Debt Issued (Repaid) | - | - | - | - | - | 1 |
Issuance of Common Stock | 181.1 | 164 | 165.9 | 167.36 | - | - |
Financing Cash Flow | 202.04 | 164 | 165.9 | 297.12 | 29.98 | 30.91 |
Net Cash Flow | 181.59 | 145.52 | -199.05 | 240.58 | 16.4 | 26.39 |
Free Cash Flow | -90.24 | -147.08 | -109.9 | -48.54 | -13.58 | -4.52 |
Free Cash Flow Per Share | -1.01 | -1.84 | -1.68 | -1.31 | -2.46 | -0.76 |
Levered Free Cash Flow | -151.71 | -82.72 | -56.86 | -37.01 | -9.6 | - |
Unlevered Free Cash Flow | -151.71 | -82.72 | -56.86 | -37.01 | -9.58 | - |
Change in Net Working Capital | -0.77 | -9.57 | -7.21 | -2.94 | 1.56 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.